Condition: Down Syndrome · Fetal Aneuploidy · Sponsor: Sequenom, Inc.
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama Birmingham | Birmingham, Alabama, United States | Recruiting |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Sharp-Rees Stealy Medical Group | San Diego, California, United States | Recruiting |
| UCSD | San Diego, California, United States | Recruiting |
| Women's Health Care Research | San Diego, California, United States | Recruiting |
| Specialty Obstetrics of San Diego | San Diego, California, United States | Recruiting |
| Reproductive Genetics Institute | Chicago, Illinois, United States | Recruiting |
| University of Iowa Health Care | Iowa City, Iowa, United States | Recruiting |
| Henry Ford Hospital | Detroit, Michigan, United States | Recruiting |
| Spectrum Health | Grand Rapids, Michigan, United States | Recruiting |
| The Cooper Health System | Camden, New Jersey, United States | Recruiting |
| Medical University of South Carolina | Charleston, South Carolina, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01429389